Hyderabad, January 28, 2025 – Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804) has announced that it will hold its Q3 FY25 earnings conference call on February 7, 2025, at 8:30 AM IST. The call will discuss the company's unaudited financial results for the quarter and nine months ended December 31, 2024.
Conference Call Details
- Date: Friday, February 7, 2025
- Time: 8:30 AM IST (India)
- Platform: Zoom (Online Webinar)
- Earnings Presentation: Will be available after the announcement of results on Aurobindo Pharma's website.
Investor Expectations
Market participants and analysts will focus on:- Revenue and profit growth in the pharmaceutical sector.
- Update on key international markets, including the US, Europe, and emerging markets.
- Product pipeline updates, R&D investments, and regulatory approvals.
- Impact of cost optimizations and pricing dynamics in the generics market.